WO2000047547A3 - Cycloalkyl amine compounds and uses thereof - Google Patents
Cycloalkyl amine compounds and uses thereof Download PDFInfo
- Publication number
- WO2000047547A3 WO2000047547A3 PCT/CA2000/000117 CA0000117W WO0047547A3 WO 2000047547 A3 WO2000047547 A3 WO 2000047547A3 CA 0000117 W CA0000117 W CA 0000117W WO 0047547 A3 WO0047547 A3 WO 0047547A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amine compounds
- compounds
- cycloalkyl amine
- compositions
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25289/00A AU2528900A (en) | 1999-02-12 | 2000-02-10 | Cycloalkyl amine compounds and uses thereof |
US09/913,373 US6979685B1 (en) | 1999-02-12 | 2000-02-10 | Cycloalkyl amine compounds and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11988799P | 1999-02-12 | 1999-02-12 | |
US60/119,887 | 1999-02-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000047547A2 WO2000047547A2 (en) | 2000-08-17 |
WO2000047547A3 true WO2000047547A3 (en) | 2000-12-14 |
Family
ID=22387012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2000/000117 WO2000047547A2 (en) | 1999-02-12 | 2000-02-10 | Cycloalkyl amine compounds and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2528900A (en) |
WO (1) | WO2000047547A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU751772C (en) | 1998-04-01 | 2006-09-07 | Correvio International Sàrl | Aminocyclohexyl ether compounds and uses thereof |
US7507545B2 (en) | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US20070099983A1 (en) | 2003-05-02 | 2007-05-03 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
US7345086B2 (en) | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
WO2005018635A2 (en) | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
US8058304B2 (en) | 2004-04-01 | 2011-11-15 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
WO2005113011A2 (en) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
JP4991037B2 (en) | 2004-04-01 | 2012-08-01 | カーディオム ファーマ コーポレイション | Drug conjugates comprising ion channel modulating compounds |
EP1868598B1 (en) | 2004-11-08 | 2014-04-23 | Cardiome Pharma Corp. | A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2259260A1 (en) * | 1972-12-04 | 1974-06-06 | Merck Patent Gmbh | 2-Pentyloxy-3-heptylamino-dialkoxy-cyclopentanes - from corresp. 1,4-substd. cpds. by hydrogenolysis or 2-R-pentyloxy-cpds. by oxidn. or thermolysis |
DE3517901A1 (en) * | 1984-05-18 | 1985-12-12 | Glaxo Group Ltd., London | AMINOCYCLOPENTYL ETHER, THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION |
JPH02270864A (en) * | 1989-04-12 | 1990-11-05 | Asahi Glass Co Ltd | Fluorocarbacyclic nucleoside and production thereof |
WO1994014435A1 (en) * | 1992-12-29 | 1994-07-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Cycloalkyl amine bis-aryl squalene synthase inhibitors |
WO1996023894A1 (en) * | 1995-02-03 | 1996-08-08 | Basf Aktiengesellschaft | Racemate separation of primary and secondary heteroatom-substituted amine by enzyme-catalysed acylation |
-
2000
- 2000-02-10 AU AU25289/00A patent/AU2528900A/en not_active Abandoned
- 2000-02-10 WO PCT/CA2000/000117 patent/WO2000047547A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2259260A1 (en) * | 1972-12-04 | 1974-06-06 | Merck Patent Gmbh | 2-Pentyloxy-3-heptylamino-dialkoxy-cyclopentanes - from corresp. 1,4-substd. cpds. by hydrogenolysis or 2-R-pentyloxy-cpds. by oxidn. or thermolysis |
DE3517901A1 (en) * | 1984-05-18 | 1985-12-12 | Glaxo Group Ltd., London | AMINOCYCLOPENTYL ETHER, THEIR PRODUCTION AND PHARMACEUTICAL FORMULATION |
JPH02270864A (en) * | 1989-04-12 | 1990-11-05 | Asahi Glass Co Ltd | Fluorocarbacyclic nucleoside and production thereof |
WO1994014435A1 (en) * | 1992-12-29 | 1994-07-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Cycloalkyl amine bis-aryl squalene synthase inhibitors |
WO1996023894A1 (en) * | 1995-02-03 | 1996-08-08 | Basf Aktiengesellschaft | Racemate separation of primary and secondary heteroatom-substituted amine by enzyme-catalysed acylation |
Non-Patent Citations (5)
Title |
---|
CHEMICAL ABSTRACTS, vol. 115, no. 5, 5 August 1991, Columbus, Ohio, US; abstract no. 50215n, MORISAWA Y ET AL: "Preparation of fluorocarbocyclic nucleosides as antitumor agents" page 904; column 2; XP002901046 * |
CHEMICAL ABSTRACTS, vol. 129, no. 17, 26 October 1998, Columbus, Ohio, US; abstract no. 216472k, CROTTI P ET AL: "Regiochemical control of the ring-opening of epoxides by means of chelating processes. Part 13. Syntheses and ring-opening reactions of the diastereoisomeric cis- and transepoxides derived from 3-(benzyloxy)cyclopentene and 2-(benzyloxy)-2,5-dihydrofuran" page 662; column 2; XP002901045 * |
CHEMICAL ABSTRACTS, vol. 89, no. 15, 9 October 1978, Columbus, Ohio, US; abstract no. 129113f, ORTH D ET AL: "Cyclopentane-1-amines" page 555; column 1; XP002901044 * |
DE 2 658 401 A (MERCK PATENT GMBH) * |
EUR.J.ORG.CHEM., no. 8, 1998, pages 1675 - 1686 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000047547A2 (en) | 2000-08-17 |
AU2528900A (en) | 2000-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2011C002I2 (en) | Aminocyclohexyl ether compounds and uses thereof | |
IL216579A0 (en) | Aminocyclohexyl ether derivatives and pharmaceutical compositions containing the same | |
EP1820790A3 (en) | 3-Alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and process for making them | |
AU2003233010A1 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
WO1999048482A3 (en) | Smilagenin and anzurogenin-d for the treatment of alzheimer's disease | |
DE69924387D1 (en) | NON-PEPTIDIC GNRH AGENTIA, METHOD AND INTERMEDIATE CONNECTIONS FOR THE PRODUCTION THEREOF | |
CA2172513A1 (en) | Aminocyclohexylesters and uses thereof | |
WO2000047547A3 (en) | Cycloalkyl amine compounds and uses thereof | |
EP1548025A3 (en) | Sapogenin derivatives and their use in the treatment of cognitive dysfunction | |
WO2001010896A3 (en) | Factor x analog with an improved ability to be activated | |
GB0112812D0 (en) | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom | |
CA2436572A1 (en) | Perylenequinones for use as photosensitizers and sonosensitizers | |
AU2003241785A1 (en) | Intravenous composition, process for producing the same and preparation thereof | |
AU2401401A (en) | Migrastatin, process for producing the same and medicinal compositions | |
WO2001000188A3 (en) | Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia | |
WO2002072534A3 (en) | 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof | |
AU5969000A (en) | Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse andparticularly pure 2,6-dichloro-5-fluoro-nicotinic acid | |
WO2003045909A3 (en) | Methods and intermediates for the synthesis of azepines | |
MY157231A (en) | Aminocyclohexyl ether compounds and uses thereof | |
AU2002327560A1 (en) | Compositions comprising rigid-rod polymers and carbon nanotubes and process for making the same | |
AU2002242962A1 (en) | Isoquinuclidine derivative, process for producing the same, and medicinal composition containing the same | |
AU2002248522A1 (en) | Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09913373 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |